A UC Berkeley-led research team discovered a new method of administering treatment for heart diseases, with the aid of a chip that mimics human heart function, according to a recent study. The study concentrated on the delivery of lipid nanoparticle-mRNA complexes. Lipid nanoparticles, or LNPs, are often used in vaccines. LNPs can also carry mRNA into damaged tissues for repair. However, according to the study brief, LNP-mRNA formulations for cardiac delivery were “lacking.” Read more through the link in bio. ✍️: Ingrid Lu 📸: Courtesy of Kevin E. Healy . . . #ucberkeley #dailycal #berkeley #ucberkeleyengineering #ucberkeleybioengineering #healylab